Skip to content

News

Ovarian Cancer Research Alliance Names Winners of Two Prizes in Recognition of Notable Research

Ovarian Cancer Research Alliance Names Winners of Two Prizes in Recognition of Notable Research

Ovarian Cancer Research Alliance (OCRA), the largest global organization dedicated to advancing ovarian and related gynecologic cancer research, announced today the recipients of two prizes awarded for noteworthy work in the field of ovarian cancer research. One honoree received the 2024 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research in recognition of his groundbreaking … Continued

New Statistics Reveal Cancer Diagnoses Rising in Women Under 50

New Statistics Reveal Cancer Diagnoses Rising in Women Under 50

Recent data from the American Cancer Society’s Cancer Facts & Figures 2025 report, also covered by NPR, reveals that cancer diagnoses among younger women are increasing, with cancer incidence rates for women under 50 now 82% higher than those for men in the same age group. For more information, read “Cancer Incidence Rate for Women … Continued

The Overview: January 2025

The Overview: January 2025

OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective April 1, 2025. This historic collaboration unites two respected organizations committed to advancing research for a cure for ovarian and all gynecologic cancers. “OCRA has always … Continued

Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer

Ovarian Cancer Research Alliance Joins with Rivkin Center for Ovarian Cancer Research, Strengthening the Fight Against Ovarian Cancer

OCRA to Expand its Research Initiatives by Integrating Rivkin Center’s Legacy Efforts, Effective April 2025 NEW YORK, NY, January 28, 2025 – Ovarian Cancer Research Alliance (OCRA), the world’s largest gynecologic cancer nonprofit, is proud to announce that the Rivkin Center for Ovarian Cancer Research will combine with OCRA, effective April 1, 2025. This historic collaboration … Continued

How OCRA-Funded Research is Harnessing AI and Nanotechnology for Earlier Ovarian Cancer Detection, a Conversation with Clarke’s Closer Look

How OCRA-Funded Research is Harnessing AI and Nanotechnology for Earlier Ovarian Cancer Detection, a Conversation with Clarke’s Closer Look

In a new interview with journalist Marcel Clarke for Clarke’s Closer Look, OCRA grantee Dr. Daniel Heller of Memorial Sloan Kettering Cancer Center discusses how his lab is utilizing artificial intelligence (AI) to develop a cutting-edge blood test to detect ovarian cancer at its earliest stages. This OCRA-funded study is in partnership with Microsoft AI … Continued

Advocate’s Corner: January 2025

Advocate’s Corner: January 2025

Happy New Year from OCRA’s Policy and Advocacy Team! As we step into a new year, we want to take a moment to thank you for your unwavering support and dedication. Each year brings fresh opportunities to drive meaningful change for the ovarian and gynecologic cancer community, and we couldn’t do it without you. Update … Continued

OCRA Surpasses Year-End Fundraising Goals, Fueling Critical Research and Patient Support Programs

OCRA Surpasses Year-End Fundraising Goals, Fueling Critical Research and Patient Support Programs

[New York, NY – January 15, 2025] – Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone in its mission to eradicate ovarian and related gynecologic cancers. Fueled by the generosity and unwavering support of donors, this achievement … Continued

OCRA-Funded Research Identifies Promising Therapeutic Strategy to Improve Immune Response Against Ovarian Cancer

OCRA-Funded Research Identifies Promising Therapeutic Strategy to Improve Immune Response Against Ovarian Cancer

A study recently published in Science Advances and supported in part by Ovarian Cancer Research Alliance has advanced scientists’ understanding of how to potentially overcome immune evasion in ovarian cancer. The research team involved current and former Memorial Sloan Kettering Cancer Center researchers, including OCRA grantee Melica Brodeur MD, MSc, now at McGill University, who … Continued

A Celebration of Community to Commence the New Year

A Celebration of Community to Commence the New Year

More than 60 gynecologic cancer patients and survivors came together at the end of December for holiday merriment, celebrating of participants’ triumphs, and embracing the new year during a special session of Ovarian Cancer Research Alliance’s online expressive arts series facilitated by our oncology social workers.  Ahead of this Express Yourself session, which centered on … Continued

The Overview: December 2024

The Overview: December 2024

A Year of Progress: Advances in the Fight Against Ovarian and All Gynecologic Cancers This year, your support enabled Ovarian Cancer Research Alliance (OCRA) to make incredible strides in research, advocacy, and patient support for those facing ovarian and all gynecologic cancers. With your help, we expanded our support programs, fostered critical collaborations, and continued … Continued

Advocate’s Corner: December 2024

Advocate’s Corner: December 2024

As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and pushing for progress for the ovarian and gynecologic cancer community have left a mark that will be felt for years to come.  Here are some … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.